Comparative Study to Evaluate the Efficacy of Smooth Muscle Relaxants and Lycopene in the Management of Oral Submucous Fibrosis Patients
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Oral submucous fibrosis (OSMF) is a chronic, potentially malignant disorder linked to areca nut chewing, characterized by progressive fibrosis, restricted mouth opening, and impaired oral functions. Standard therapies such as corticosteroids and antioxidants yield variable outcomes. Objective: To compare the efficacy of smooth muscle relaxants (chlorzoxazone) and lycopene, in combination with intralesional corticosteroids, on clinical outcomes in OSMF patients. Methods: Forty patients with clinically diagnosed OSMF were randomly divided into two groups. Group A received intralesional triamcinolone acetonide with lycopene, and Group B received intralesional triamcinolone acetonide with chlorzoxazone. Mouth opening, burning sensation, and tongue protrusion were recorded at baseline and at 15-day intervals for 90 days. Data were analyzed using the independent t -test and Chi-square test. Results: Both groups showed significant improvements. Group B demonstrated a greater increase in mouth opening (19.21–32.34 mm, P < 0.05), while reductions in burning sensation and improvements in tongue protrusion were comparable between the groups ( P > 0.05). Conclusion: Smooth muscle relaxants, as an adjunct to corticosteroid therapy, provide superior improvement in mouth opening and represent a valuable addition to OSMF management.
Fields of Study & Subjects
Oral Health Pathology and Treatment
Oral health in cancer treatment
HIV/AIDS oral health manifestations
Publication details
- Journal / source
- Journal of Indian Academy of Oral Medicine and Radiology
- Volume
- 38
- Issue
- 1
- Pages
- 110–114
- Publication date
- 1 January 2026
- Language
- EN